Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
Shipra Das(Cellectis (United States)), Laurent Poirot(Epigénétique et Destin Cellulaire)
Cited by 2
Related Papers
An oxygen sensitive self-decision making engineered CAR T-cell
|Scientific Reports|2017|223
Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
|Frontiers in Immunology|2023|50
TALEN-edited allogeneic inducible dual CAR T cells enable effective targeting of solid tumors while mitigating off-tumor toxicity
|Molecular Therapy|2024|31
Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies
|Cancer Immunology Research|2023|9